Global Pharmaceutical Chemicals Market – Industry Analysis and Forecast (2019-2026) – by Product, by Application and by Region.

Global Pharmaceutical Chemicals Market was valued US$ 83.90 Bn and is expected to reach US$ XX Bn by 2026 at a CAGR of XX %. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report Demand of Pharmaceutical chemicals has been increasing on account of rising population and access to healthcare in developing countries. Regionally, major demand is expected to come from developing countries thanks to government’s spending on healthcare and increasing per capita income. Pharmaceutical chemical industry is looking at developing and European countries to open new revenue models. Obesity and unhealthy lifestyle, increasing life expectancy are some key drivers driving the growth of the market. Increasing cases of chronic disorders like cardiovascular, neurological, oncological, infectious, metabolic system, diabetes, respiratory, gastrointestinal, and musculoskeletal some of drivers keeping the demand constant in developed countries and increasing at faster rate in developing countries. The report has covered the drivers and restraints of the market by region by taking each important country into account. The report will give the detailed region-wise analysis of market size, key trends, drivers, opportunities, major players and their strategies etc. Cardiovascular is anticipated to be the fastest growing application segment during the forecast growing at a CAGR of 8 %. According to the World Health Organization (WHO) cardiovascular diseases are observed to be the primary cause of fatalities. An escalating population has been continuously adding to the demand for generic as well as proprietary drugs as the people aged over 60 invariably suffer from numerous chronic diseases particularly cardiovascular, respiratory, diabetes, and vitamin deficiency. Advanced intermediates are estimated to be the fastest growing product segment over the forecast period. Advanced Intermediates comprises the basis and fine chemical. Organometallics is a recent segment introduced to the portfolio at the Advanced Industrial Intermediates. North America was the largest contributor to the global pharmaceutical chemicals market in 2018. Europe is the second largest contributor of the global pharmaceutical chemicals market and is expected to grow further during the forecast period. The Asia Pacific is expected to be the fastest growing market due to the increase in drug manufacturing and consumer base. Market major participants include Angelini Acraf S.p.A, Albermarle Corporation, Chemada Fine Chemicals, W.R. Grace & Co., and Kenko Corporation, Abbott, Akzo Nobel N.V, Albemarle Corporation, AstraZeneca, BASF SE, Boehringer Ingelheim GmbH, Clariant AG, Eastman Chemical Company, Evonik Industries, GlaxoSmithKline, Lonza Group Ltd, Merck and co., Roche, Royal DSM N.V and The Dow Chemical Company. The objective of the report is to present comprehensive analysis of Allergy Relieving Eye Drops Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Allergy Relieving Eye Drops Market dynamics, structure by analyzing the market segments, and project the Allergy Relieving Eye Drops Market size. Clear representation of competitive analysis of key players by Allergy Relieving Eye Drops Type, price, financial position, product portfolio, growth strategies, and regional presence in the Allergy Relieving Eye Drops Market make the report investor’s guide.

Scope of the Global Pharmaceutical Chemicals: Inquire before buying

Global Pharmaceutical Chemicals, by Product:

• Basic building blocks • Advanced intermediates • Active ingredients

Global Pharmaceutical Chemicals, by Application:

• Cardiovascular • Neurology • Oncology • Infectious diseases • Metabolic system • Diabetes • Respiratory diseases • Gastrointestinal diseases • Musculoskeletal diseases • Other

Key Players analysed in Global Pharmaceutical Chemicals:

• Dishman Group • Johnson-Matthey • Lonza Group • Lanxess AG • Jubilant Life Sciences • Vertellus Holdings LLC • Porton • Hikal • Celanese AG • Easter Chemical Corporation • Abbott • Akzo Nobel N.V • Albemarle Corporation • AstraZeneca • BASF SE • Boehringer Ingelheim GmbH • Clariant AG • Eastman Chemical Company • Evonik Industries • GlaxoSmithKlein • Lonza Group Ltd • Merck and co. • Roche • Royal DSM N.V. • The Dow Chemical Company

Global Pharmaceutical Chemicals Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Abbreviations Used 2.2. Report Assumptions 2.3. Research Methodology 3. Executive Summary 3.1. Global Pharmaceutical Chemical Market Volume and Value (US$ Bn), by Region 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Challenges 4.2.4. Emerging Technology 4.3. Market Analysis 4.3.1. Value Chain Analysis 4.3.2. Pricing Analysis 4.3.3. Market Risk analysis 4.3.4. Patent Analysis 4.3.5. Porter’s Analysis 5. Global Pharmaceutical Chemical Market Analysis and Forecast 5.1. Global Pharmaceutical Chemical Market Analysis and Forecast 5.2. Global Pharmaceutical Chemical Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. South America 6. Global Pharmaceutical Chemical Market Analysis and Forecast, by Product 6.1. Introduction and Definition 6.2. Global Pharmaceutical Chemical Market Size (US$ Mn) Forecast, by Product 6.3. Global Pharmaceutical Chemical Market Value Share Analysis, by Product 6.4. Global Pharmaceutical Chemical Market Attractiveness Analysis, by Product 6.5. Key Trends 6.6. Key Developments 7. Global Pharmaceutical Chemical Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Global Pharmaceutical Chemical Market Size (US$ Mn) Forecast, by Application 7.3. Global Pharmaceutical Chemical Market Value Share Analysis, by Application 7.4. Global Pharmaceutical Chemical Market Attractiveness Analysis, by Application 8. Global Pharmaceutical Chemical Market Analysis, by Region 8.1. Global Pharmaceutical Chemical Market Size (US$ Mn) Forecast, by Region 8.2. Global Pharmaceutical Chemical Market Value Share Analysis, by Region 8.3. Global Pharmaceutical Chemical Market Attractiveness Analysis, by Region 9. North America Pharmaceutical Chemical Market Analysis 9.1. North America Pharmaceutical Chemical Market Overview 9.2. North America Pharmaceutical Chemical Market Value Share Analysis, by Product 9.3. North America Pharmaceutical Chemical Market Forecast, by Product 9.3.1. Basic building blocks 9.3.2. Advanced intermediates 9.3.3. Active ingredients 9.4. North America Pharmaceutical Chemical Market Value Share Analysis, by Application 9.5. North America Pharmaceutical Chemical Market Forecast, by Application 9.5.1. Cardiovascular 9.5.2. Neurology 9.5.3. Oncology 9.5.4. Infectious diseases 9.5.5. Metabolic system 9.5.6. Diabetes 9.5.7. Respiratory diseases 9.5.8. Gastrointestinal diseases 9.5.9. Musculoskeletal diseases 9.5.10. Other 9.6. North America Pharmaceutical Chemical Market Value Share Analysis, by Country 9.7. North America Pharmaceutical Chemical Market Forecast, by Country 9.7.1. U.S. 9.7.2. Canada. 9.8. U.S. Pharmaceutical Chemical Market Forecast, by Product 9.8.1. Basic building blocks 9.8.2. Advanced intermediates 9.8.3. Active ingredients 9.9. U.S. Pharmaceutical Chemical Market Forecast, by Application 9.9.1. Cardiovascular 9.9.2. Neurology 9.9.3. Oncology 9.9.4. Infectious diseases 9.9.5. Metabolic system 9.9.6. Diabetes 9.9.7. Respiratory diseases 9.9.8. Gastrointestinal diseases 9.9.9. Musculoskeletal diseases 9.9.10. Other 9.10. Canada Pharmaceutical Chemical Market Forecast, by Product 9.10.1. Basic building blocks 9.10.2. Advanced intermediates 9.10.3. Active ingredients 9.11. Canada Pharmaceutical Chemical Market Forecast, by Application 9.11.1. Cardiovascular 9.11.2. Neurology 9.11.3. Oncology 9.11.4. Infectious diseases 9.11.5. Metabolic system 9.11.6. Diabetes 9.11.7. Respiratory diseases 9.11.8. Gastrointestinal diseases 9.11.9. Musculoskeletal diseases 9.11.10. Other 9.12. North America Pharmaceutical Chemical Market Attractiveness Analysis 9.12.1. By Product 9.12.2. By Application 10. Europe Pharmaceutical Chemical Market Analysis 10.1. Europe Pharmaceutical Chemical Market Overview 10.2. Europe Pharmaceutical Chemical Market Value Share Analysis, by Product 10.3. Europe Pharmaceutical Chemical Market Forecast, by type 10.3.1. Basic building blocks 10.3.2. Advanced intermediates 10.3.3. Active ingredients 10.4. Europe Pharmaceutical Chemical Market Value Share Analysis, by Application 10.5. Europe Pharmaceutical Chemical Market Forecast, by Application 10.5.1. Cardiovascular 10.5.2. Neurology 10.5.3. Oncology 10.5.4. Infectious diseases 10.5.5. Metabolic system 10.5.6. Diabetes 10.5.7. Respiratory diseases 10.5.8. Gastrointestinal diseases 10.5.9. Musculoskeletal diseases 10.5.10. Other 10.6. Europe Pharmaceutical Chemical Market Forecast, by Country 10.6.1. Germany 10.6.2. U.K. 10.6.3. France 10.6.4. Italy 10.6.5. Spain 10.6.6. Rest of Europe 10.7. Europe Pharmaceutical Chemical Market Analysis, by Country/ Sub-region 10.8. Germany Pharmaceutical Chemical Market Forecast, by Product 10.8.1. Basic building blocks 10.8.2. Advanced intermediates 10.8.3. Active ingredients 10.9. Germany Pharmaceutical Chemical Market Forecast, by Application 10.9.1. Cardiovascular 10.9.2. Neurology 10.9.3. Oncology 10.9.4. Infectious diseases 10.9.5. Metabolic system 10.9.6. Diabetes 10.9.7. Respiratory diseases 10.9.8. Gastrointestinal diseases 10.9.9. Musculoskeletal diseases 10.9.10. Other 10.10. U.K. Pharmaceutical Chemical Market Forecast, by Product 10.10.1. Basic building blocks 10.10.2. Advanced intermediates 10.10.3. Active ingredients 10.11. U.K. Pharmaceutical Chemical Market Forecast, by Application 10.11.1. Cardiovascular 10.11.2. Neurology 10.11.3. Oncology 10.11.4. Infectious diseases 10.11.5. Metabolic system 10.11.6. Diabetes 10.11.7. Respiratory diseases 10.11.8. Gastrointestinal diseases 10.11.9. Musculoskeletal diseases 10.11.10. Other 10.12. France Pharmaceutical Chemical Market Forecast, by Product 10.12.1. Basic building blocks 10.12.2. Advanced intermediates 10.12.3. Active ingredients 10.13. France Pharmaceutical Chemical Market Forecast, by Application 10.13.1. Cardiovascular 10.13.2. Neurology 10.13.3. Oncology 10.13.4. Infectious diseases 10.13.5. Metabolic system 10.13.6. Diabetes 10.13.7. Respiratory diseases 10.13.8. Gastrointestinal diseases 10.13.9. Musculoskeletal diseases 10.13.10. Other 10.14. Italy Pharmaceutical Chemical Market Forecast, by Product 10.14.1. Basic building blocks 10.14.2. Advanced intermediates 10.14.3. Active ingredients 10.15. Italy Pharmaceutical Chemical Market Forecast, by Application 10.15.1. Cardiovascular 10.15.2. Neurology 10.15.3. Oncology 10.15.4. Infectious diseases 10.15.5. Metabolic system 10.15.6. Diabetes 10.15.7. Respiratory diseases 10.15.8. Gastrointestinal diseases 10.15.9. Musculoskeletal diseases 10.15.10. Other 10.16. Spain Pharmaceutical Chemical Market Forecast, by Product 10.16.1. Basic building blocks 10.16.2. Advanced intermediates 10.16.3. Active ingredients 10.17. Spain Pharmaceutical Chemical Market Forecast, by Application 10.17.1. Cardiovascular 10.17.2. Neurology 10.17.3. Infectious diseases 10.17.4. Metabolic system 10.17.5. Diabetes 10.17.6. Respiratory diseases 10.17.7. Gastrointestinal diseases 10.17.8. Musculoskeletal diseases 10.17.9. Other 10.18. Rest of Europe Pharmaceutical Chemical Market Forecast, by Product 10.18.1. Basic building blocks 10.18.2. Advanced intermediates 10.18.3. Active ingredients 10.19. Rest of Europe Pharmaceutical Chemical Market Forecast, by Application 10.19.1. Cardiovascular 10.19.2. Neurology 10.19.3. Oncology 10.19.4. Infectious diseases 10.19.5. Metabolic system 10.19.6. Diabetes 10.19.7. Respiratory diseases 10.19.8. Gastrointestinal diseases 10.19.9. Musculoskeletal diseases 10.19.10. Other 10.20. Europe Pharmaceutical Chemical Market Attractiveness Analysis 10.20.1. By Product 10.20.2. By Application 10.21. PEST Analysis 10.22. Key Trends 10.23. Key Developments 11. Asia Pacific Pharmaceutical Chemical Market Analysis 11.1. Asia Pacific Pharmaceutical Chemical Market Overview 11.2. Asia Pacific Pharmaceutical Chemical Market Value Share Analysis, by Product 11.3. Asia Pacific Pharmaceutical Chemical Market Forecast, by type 11.3.1. Basic building blocks 11.3.2. Advanced intermediates 11.3.3. Active ingredients 11.4. Asia Pacific Pharmaceutical Chemical Market Value Share Analysis, by Application 11.5. Asia Pacific Pharmaceutical Chemical Market Forecast, by Application 11.5.1. Cardiovascular 11.5.2. Neurology 11.5.3. Oncology 11.5.4. Infectious diseases 11.5.5. Metabolic system 11.5.6. Diabetes 11.5.7. Respiratory diseases 11.5.8. Gastrointestinal diseases 11.5.9. Musculoskeletal diseases 11.5.10. Other 11.6. Asia Pacific Pharmaceutical Chemical Market Value Share Analysis, by Country 11.7. Asia Pacific Pharmaceutical Chemical Market Forecast, by Country 11.7.1. China. 11.7.2. India. 11.7.3. Japan. 11.7.4. ASEAN. 11.7.5. Rest of Asia Pacific. 11.8. Asia Pacific Pharmaceutical Chemical Market Analysis, by Country/ Sub-region 11.9. China Pharmaceutical Chemical Market Forecast, by Product 11.9.1. Basic building blocks 11.9.2. Advanced intermediates 11.9.3. Active ingredients 11.10. China Pharmaceutical Chemical Market Forecast, by Application 11.10.1. Cardiovascular 11.10.2. Neurology 11.10.3. Oncology 11.10.4. Infectious diseases 11.10.5. Metabolic system 11.10.6. Diabetes 11.10.7. Respiratory diseases 11.10.8. Gastrointestinal diseases 11.10.9. Musculoskeletal diseases 11.10.10. Other 11.11. India Pharmaceutical Chemical Market Forecast, by type 11.11.1. Basic building blocks 11.11.2. Advanced intermediates 11.11.3. Active ingredients 11.12. India Pharmaceutical Chemical Market Forecast, by Application 11.12.1. Cardiovascular 11.12.2. Neurology 11.12.3. Oncology 11.12.4. Infectious diseases 11.12.5. Metabolic system 11.12.6. Diabetes 11.12.7. Respiratory diseases 11.12.8. Gastrointestinal diseases 11.12.9. Musculoskeletal diseases 11.12.10. Other 11.13. ASEAN Pharmaceutical Chemical Market Forecast, by Product 11.13.1. Basic building blocks 11.13.2. Advanced intermediates 11.13.3. Active ingredients 11.14. ASEAN Pharmaceutical Chemical Market Forecast, by Application 11.14.1. Cardiovascular 11.14.2. Neurology 11.14.3. Oncology 11.14.4. Infectious diseases 11.14.5. Metabolic system 11.14.6. Diabetes 11.14.7. Respiratory diseases 11.14.8. Gastrointestinal diseases 11.14.9. Musculoskeletal diseases 11.14.10. Other 11.15. Rest of Asia Pacific Pharmaceutical Chemical Market Forecast, by Product 11.15.1. Basic building blocks 11.15.2. Advanced intermediates 11.15.3. Active ingredients 11.16. Rest of Asia Pacific Pharmaceutical Chemical Market Forecast, by Application 11.16.1. Cardiovascular 11.16.2. Neurology 11.16.3. Oncology 11.16.4. Infectious diseases 11.16.5. Metabolic system 11.16.6. Diabetes 11.16.7. Respiratory diseases 11.16.8. Gastrointestinal diseases 11.16.9. Musculoskeletal diseases 11.16.10. Other 11.17. Asia Pacific Pharmaceutical Chemical Market Attractiveness Analysis 11.17.1. By Product 11.17.2. By Application 11.18. PEST Analysis 11.19. Key Trends 12. Key Developments 13. Middle East & Africa Pharmaceutical Chemical Market Analysis 13.1. Middle East & Africa Pharmaceutical Chemical Market Overview 13.2. Middle East & Africa Pharmaceutical Chemical Market Value Share Analysis, by Product 13.3. Middle East & Africa Pharmaceutical Chemical Market Forecast, by Product 13.3.1. Basic building blocks 13.3.2. Advanced intermediates 13.3.3. Active ingredients 13.4. Middle East & Africa Pharmaceutical Chemical Market Value Share Analysis, by Application 13.5. Middle East & Africa Pharmaceutical Chemical Market Forecast, by Application 13.5.1. Cardiovascular 13.5.2. Neurology 13.5.3. Oncology 13.5.4. Infectious diseases 13.5.5. Metabolic system 13.5.6. Diabetes 13.5.7. Respiratory diseases 13.5.8. Gastrointestinal diseases 13.5.9. Musculoskeletal diseases 13.5.10. Other 13.6. Middle East & Africa Pharmaceutical Chemical Market Value Share Analysis, by Country 13.7. Middle East & Africa Pharmaceutical Chemical Market Forecast, by Country 13.7.1. GCC. 13.7.2. South Africa. 13.7.3. Rest of Middle East & Africa. 13.8. Middle East & Africa Pharmaceutical Chemical Market Analysis, by Country/ Sub-region 13.9. GCC Pharmaceutical Chemical Market Forecast, by Product 13.9.1. Basic building blocks 13.9.2. Advanced intermediates 13.9.3. Active ingredients 13.10. GCC Pharmaceutical Chemical Market Forecast, by Application 13.10.1. Cardiovascular 13.10.2. Neurology 13.10.3. Oncology 13.10.4. Infectious diseases 13.10.5. Metabolic system 13.10.6. Diabetes 13.10.7. Respiratory diseases 13.10.8. Gastrointestinal diseases 13.10.9. Musculoskeletal diseases 13.10.10. Other 13.11. South Africa Pharmaceutical Chemical Market Forecast, by Product 13.11.1. Basic building blocks 13.11.2. Advanced intermediates 13.11.3. Active ingredients 13.12. South Africa Pharmaceutical Chemical Market Forecast, by Application 13.12.1. Cardiovascular 13.12.2. Neurology 13.12.3. Oncology 13.12.4. Infectious diseases 13.12.5. Metabolic system 13.12.6. Diabetes 13.12.7. Respiratory diseases 13.12.8. Gastrointestinal diseases 13.12.9. Musculoskeletal diseases 13.12.10. Other 13.13. Rest of Middle East & Africa Pharmaceutical Chemical Market Forecast, by type 13.13.1. Basic building blocks 13.13.2. Advanced intermediates 13.13.3. Active ingredients 13.14. Rest of Middle East & Africa Pharmaceutical Chemical Market Forecast, by Application 13.14.1. Cardiovascular 13.14.2. Neurology 13.14.3. Oncology 13.14.4. Infectious diseases 13.14.5. Metabolic system 13.14.6. Diabetes 13.14.7. Respiratory diseases 13.14.8. Gastrointestinal diseases 13.14.9. Musculoskeletal diseases 13.14.10. Other 13.15. Middle East & Africa Pharmaceutical Chemical Market Attractiveness Analysis 13.15.1. By Product 13.15.2. By Application 13.16. PEST Analysis 13.17. Key Trends 14. Key Developments 15. South America Pharmaceutical Chemical Market Analysis 15.1. South America Pharmaceutical Chemical Market Overview 15.2. South America Pharmaceutical Chemical Market Value Share Analysis, by Product 15.3. South America Pharmaceutical Chemical Market Forecast, by Product 15.3.1. Basic building blocks 15.3.2. Advanced intermediates 15.3.3. Active ingredients 15.4. South America Pharmaceutical Chemical Market Value Share Analysis, by Application 15.5. South America Pharmaceutical Chemical Market Forecast, by Application 15.5.1. Cardiovascular 15.5.2. Neurology 15.5.3. Oncology 15.5.4. Infectious diseases 15.5.5. Metabolic system 15.5.6. Diabetes 15.5.7. Respiratory diseases 15.5.8. Gastrointestinal diseases 15.5.9. Musculoskeletal diseases 15.5.10. Other 15.6. South America Pharmaceutical Chemical Market Value Share Analysis, by Country 15.7. South America Pharmaceutical Chemical Market Forecast, by Country 15.7.1. Brazil 15.7.2. Mexico 15.7.3. Rest of South America 15.8. South America Pharmaceutical Chemical Market Analysis, by Country/ Sub-region 15.9. Brazil Pharmaceutical Chemical Market Forecast, by Product 15.9.1. Basic building blocks 15.9.2. Advanced intermediates 15.9.3. Active ingredients 15.10. Brazil Pharmaceutical Chemical Market Forecast, by Application 15.10.1. Cardiovascular 15.10.2. Neurology 15.10.3. Oncology 15.10.4. Infectious diseases 15.10.5. Metabolic system 15.10.6. Diabetes 15.10.7. Respiratory diseases 15.10.8. Gastrointestinal diseases 15.10.9. Musculoskeletal diseases 15.10.10. Other 15.11. Mexico Pharmaceutical Chemical Market Forecast, by Product 15.11.1. Basic building blocks 15.11.2. Advanced intermediates 15.11.3. Active ingredients 15.12. Mexico Pharmaceutical Chemical Market Forecast, by Application 15.12.1. Cardiovascular 15.12.2. Neurology 15.12.3. Oncology 15.12.4. Infectious diseases 15.12.5. Metabolic system 15.12.6. Diabetes 15.12.7. Respiratory diseases 15.12.8. Gastrointestinal diseases 15.12.9. Musculoskeletal diseases 15.12.10. Other 15.13. Rest of South America Pharmaceutical Chemical Market Forecast, by Product 15.13.1. Basic building blocks 15.13.2. Advanced intermediates 15.13.3. Active ingredients 15.14. South America Pharmaceutical Chemical Market Attractiveness Analysis 15.14.1. By Product 15.14.2. By Application 15.15. PEST Analysis 15.16. Key Trends 15.17. Key Developments 16. Competitive Landscape 16.1. Market Share Analysis, by Key Players 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. Market Consolidation 16.2.2.1. M&A by regions, investment, applications M&A Key Players, forward integration, backward integration 16.3. Company Profiles: Key Player 16.4. Dishman Group 16.4.1. Company Overview 16.4.2. Financial Overview 16.4.3. Business Strategy 16.4.4. Recent Developments 16.4.5. Manufacturing Footprint 16.5. Johnson-Matthey 16.6. Lonza Group 16.7. Lanxess AG 16.8. Jubilant Life Sciences 16.9. Vertellus Holdings LLC 16.10. Porton 16.11. Hikal 16.12. Celanese AG 16.13. Easter Chemical Corporation 16.14. Abbott 16.15. Akzo Nobel N.V 16.16. Albemarle Corporation 16.17. AstraZeneca 16.18. BASF SE 16.19. Boehringer Ingelheim GmbH 16.20. Clariant AG 16.21. Eastman Chemical Company 16.22. Evonik Industries 16.23. GlaxoSmithKlein 16.24. Lonza Group Ltd 16.25. Merck and co. 16.26. Roche 16.27. Royal DSM N.V. 16.28. The Dow Chemical Company 17. Appendix

About This Report

Report ID 21783
Category Material & Chemical
Published Date September 2019
Updated Date Aug 2020
Contact Us